RESUMO
Two distinct nonapeptide systems, vasotocin- and oxytocin-related peptides, evolved in vertebrates. Their role in male zebrafish reproduction has not been formally investigated. We hypothesized that the teleost nonapeptides vasotocin and isotocin stimulate male zebrafish reproductive physiology and success by affecting central neuronal and/or peripheral endocrine pathways. Pharmacological inhibition experiments revealed that both vasotocin and isotocin contribute significantly to male reproductive success, which in the case of vasotocin correlated significantly with indices of male courtship behavior. Interestingly, co-administration of vasotocin and isotocin antagonists completely abolished male reproductive success without affecting male courtship behavior and endocrine indices, possibly linked to a synergistic action of nonapeptides on male pheromone release. To further probe the nonapeptides' role in male zebrafish reproduction, we subsequently tested whether male zebrafish nonapeptide systems were acutely activated by the female releaser pheromone PGF2α, a strong chemoattractant and important reproductive cue in males which stimulates courtship behavior. Male zebrafish attracted to PGF2α in a choice assay exhibited acute increases in neuronal activation marker p-ERK immunoreactivity in the ventral glomerulus of the olfactory bulb and the preoptic area, however no co-localization with isotocin was observed. Conversely, PGF2α time-dependently stimulated whole brain isotocin mRNA abundance, suggesting secondary longer-term effects of PGF2α exposure on the central isotocinergic system. While the current lack of vasotocin-specific antibodies for zebrafish does not allow to probe acute activation of vasotocinergic neurons, whole brain vasotocin mRNA was not significantly affected by PGF2α exposure. Together, our results identify a role for nonapeptides in male zebrafish reproductive physiology and success.
Assuntos
Encéfalo/metabolismo , Ocitocina/análogos & derivados , Reprodução/fisiologia , Vasotocina/biossíntese , Proteínas de Peixe-Zebra/biossíntese , Peixe-Zebra/metabolismo , Animais , Masculino , Neurônios/metabolismo , Ocitocina/biossíntese , Ocitocina/genética , Vasotocina/genética , Peixe-Zebra/genética , Proteínas de Peixe-Zebra/genéticaRESUMO
A 35-year-old Malaysian man presented with rapid onset of flaccid quadriparesis associated with nausea and vomiting. General blood tests revealed severe hypokalaemia (serum potassium 1.5 mmol/L) and hypophosphataemia (serum phosphate 0.29 mmol/L) as a potential cause of the flaccid paralysis. Arterial blood gases showed mixed acid base disturbance of respiratory alkalosis and metabolic acidosis with hyperlactataemia. Thyrotoxic periodic paralysis (TPP) was suspected as the underlying cause of this presentation and thyroid function tests showed severe hyperthyroid results (free T4 > 77.2 pmol/L, free T3 19.3 pmol/L, thyroid-stimulating hormone [TSH] < 0.05 mIU/L). Treatment with intravenous potassium and phosphate infusion and oral propranolol resulted in rapid resolution of his symptoms. A discussion of the clinical and pathophysiological features and treatment of TPP (a very rare encounter in UK clinical practice) is presented, and to our knowledge associated hyperlactataemia has not been previously described.
Assuntos
Paralisia Periódica Hipopotassêmica/diagnóstico , Tireotoxicose/diagnóstico , Administração Oral , Adulto , Povo Asiático , Diagnóstico Diferencial , Humanos , Paralisia Periódica Hipopotassêmica/complicações , Paralisia Periódica Hipopotassêmica/etnologia , Malásia , Masculino , Fosfatos/uso terapêutico , Potássio/uso terapêutico , Propranolol/administração & dosagem , Tireotoxicose/complicações , Tireotoxicose/etnologiaRESUMO
A 73 year old white man presented with life threatening hypokalaemic paralysis requiring admission to an intensive care unit. Biochemical investigations showed severe hypokalaemia with hyperchloraemic metabolic acidosis, a spot urine pH of 6.5, and a positive urinary anion gap, establishing the diagnosis of distal renal tubular acidosis. Autoimmune tests revealed Sjögren syndrome as the underlying cause of the distal renal tubular acidosis. Full recovery followed potassium and alkali replacement. This dramatic presentation of Sjögren syndrome has not previously been reported in an elderly man.
Assuntos
Hipopotassemia/etiologia , Paralisia/etiologia , Síndrome de Sjogren/complicações , Acidose Tubular Renal/etiologia , Idoso , Humanos , MasculinoAssuntos
Doenças das Glândulas Suprarrenais/fisiopatologia , Coma/complicações , Hipoglicemia/complicações , Ácido 3-Hidroxibutírico/urina , Doenças das Glândulas Suprarrenais/sangue , Doenças das Glândulas Suprarrenais/complicações , Hormônio Adrenocorticotrópico/deficiência , Peptídeo C/sangue , Coma/sangue , Feminino , Humanos , Hipoglicemia/sangue , Insulina/sangue , Cetonas/urina , Hormônios Tireóideos/sangueAssuntos
Pessoal de Laboratório Médico , Patologia Clínica , Papel do Médico , Medicina Clínica , HumanosRESUMO
A young woman presented with progressive yellowing of her skin over a period of six months. Liver function tests were requested by her general practitioner and the results prompted the Chemical Pathology Department to instigate further tests to reach the final diagnosis. Hypercarotenaemia had caused her yellow skin, and various other biochemical abnormalities pointed towards primary hypothyroidism as an underlying cause. Thyroxine replacement treatment successfully corrected all the biochemical abnormalities including hypercarotenaemia. As far as is known, yellow skin as a sole presenting feature of hypothyroidism is extremely rare.
Assuntos
Hipotireoidismo/complicações , Transtornos da Pigmentação/etiologia , Adulto , Carotenoides/sangue , Feminino , Humanos , Hipotireoidismo/sangue , Testes de Função Hepática , Testes de Função Tireóidea , Fatores de TempoRESUMO
The aim of this study was to compare the effectiveness of subcutaneous and intravenous fluid therapy in hydrating, elderly acute stroke patients. Thirty-four such patients, needing parenteral fluids because of impaired consciousness or dysphagia, were randomly allocated to receive either subcutaneous or intravenous fluids (2 litres of dextrose-saline/24 hours). Serum osmolality was measured before starting fluid therapy (Day 1) and on Days 2 and 3. An analysis of covariance of the osmolalities showed no statistical difference between the two groups (P = 0.12). The total cost of cannulae used over the 3 days for the subcutaneous route was approximately a third of that for the intravenous route. Complication rates were similar for the two groups. The results suggest that subcutaneous fluid therapy is an effective alternative to the intravenous route.